Hudson Frederick M. — SEC Form 4 filings
SEC reporting owner CIK 1438462. 14 Form 4 filings on record with FilingPulse; latest filed 2026-03-16.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-26 to 2026-03-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 21,548 shares, $903,292 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 22.
- Largest priced transaction: sale of 8,722 shares @ $36.28 ($316,434) in SUPERNUS PHARMACEUTICALS, INC., filed 2024-11-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Director | 11 | — | 3 legs · 21,548 sh · $903,292 | 16 |
| scPharmaceuticals Inc. (SCPH) | Director | 3 | — | — | 6 |
Form 4 filings — Hudson Frederick M.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-16 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale (S): 5,369 @ $50.61 | EDGAR |
| 2026-02-25 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 4,475 @ $0 · Disposition to issuer (D): 4,475 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 2,989 (derivative) @ $0 · Grant/award (A): 4,977 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 15,000 @ $12.98 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2025-10-07 | 4 | scPharmaceuticals Inc. (SCPH) | Disposition to issuer (D): 30,000 (derivative) @ $0 · Disposition to issuer (D): 19,750 (derivative) @ $0 · Disposition to issuer (D): 16,300 (derivative) @ $0 · Disposition to issuer (D): 6,124 (derivative) @ $0 | EDGAR |
| 2025-08-18 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale (S): 7,457 @ $42.26 | EDGAR |
| 2025-06-05 | 4 | scPharmaceuticals Inc. (SCPH) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 5,369 @ $0 · Disposition to issuer (D): 5,369 (derivative) @ $0 | EDGAR |
| 2025-02-21 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 7,296 (derivative) @ $0 · Grant/award (A): 4,475 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Option exercise (M): 20,000 @ $9.13 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
| 2024-11-12 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Sale (S): 8,722 @ $36.28 | EDGAR |
| 2024-06-13 | 4 | scPharmaceuticals Inc. (SCPH) | Grant/award (A): 19,750 (derivative) @ $0 | EDGAR |
| 2024-02-27 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 3,886 @ $0 · Disposition to issuer (D): 3,886 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | SUPERNUS PHARMACEUTICALS, INC. (SUPN) | Grant/award (A): 8,252 (derivative) @ $0 · Grant/award (A): 5,369 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1438462 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →